Elekta AB (OTCMKTS:EKTAY – Get Free Report) was the recipient of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totalling 100 shares, a decrease of 66.7% from the June 30th total of 300 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average trading volume of 5,600 shares, the short-interest ratio is presently 0.0 days.
Elekta Price Performance
EKTAY stock opened at $4.96 on Thursday. Elekta has a 1 year low of $4.36 and a 1 year high of $7.13. The company has a market cap of $1.90 billion, a P/E ratio of 99.22 and a beta of 1.20. The firm has a 50-day moving average of $5.07 and a 200 day moving average of $5.30. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.09 and a quick ratio of 0.86.
Elekta (OTCMKTS:EKTAY – Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.02). The company had revenue of $503.22 million during the quarter, compared to the consensus estimate of $507.19 million. Elekta had a return on equity of 11.55% and a net margin of 1.15%. On average, sell-side analysts forecast that Elekta will post 0.36 EPS for the current year.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on Elekta
Elekta Company Profile
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
See Also
- Five stocks we like better than Elekta
- Basic Materials Stocks Investing
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- Asset Allocation Strategies in Volatile Markets
- How Marvell Went From Short Target to Breakout Star
- Following Congress Stock Trades
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.